SG10201806532RA - Proteins targeting orthologs - Google Patents
Proteins targeting orthologsInfo
- Publication number
- SG10201806532RA SG10201806532RA SG10201806532RA SG10201806532RA SG10201806532RA SG 10201806532R A SG10201806532R A SG 10201806532RA SG 10201806532R A SG10201806532R A SG 10201806532RA SG 10201806532R A SG10201806532R A SG 10201806532RA SG 10201806532R A SG10201806532R A SG 10201806532RA
- Authority
- SG
- Singapore
- Prior art keywords
- orthologs
- proteins targeting
- polypeptide
- present
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461924487P | 2014-01-07 | 2014-01-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201806532RA true SG10201806532RA (en) | 2018-09-27 |
Family
ID=53524311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201806532RA SG10201806532RA (en) | 2014-01-07 | 2015-01-07 | Proteins targeting orthologs |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11293929B2 (fr) |
| EP (2) | EP3092491B1 (fr) |
| CN (2) | CN105849564B (fr) |
| AU (2) | AU2015204840B2 (fr) |
| CA (1) | CA2935577C (fr) |
| DK (2) | DK3092491T3 (fr) |
| ES (2) | ES2819865T3 (fr) |
| SG (1) | SG10201806532RA (fr) |
| WO (1) | WO2015105888A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3966227A1 (fr) | 2019-05-07 | 2022-03-16 | Voyager Therapeutics, Inc. | Compositions et méthodes d'augmentation vectorisée de la destruction, de l'expression et/ou de la régulation de protéines |
| US20220414855A1 (en) * | 2021-06-25 | 2022-12-29 | Fei Company | Area selection in charged particle microscope imaging |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4196265A (en) | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4361549A (en) | 1979-04-26 | 1982-11-30 | Ortho Pharmaceutical Corporation | Complement-fixing monoclonal antibody to human T cells, and methods of preparing same |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4957858A (en) | 1986-04-16 | 1990-09-18 | The Salk Instute For Biological Studies | Replicative RNA reporter systems |
| US4883750A (en) | 1984-12-13 | 1989-11-28 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| AU622104B2 (en) | 1987-03-11 | 1992-04-02 | Sangtec Molecular Diagnostics Ab | Method of assaying of nucleic acids, a reagent combination and kit therefore |
| AU622426B2 (en) | 1987-12-11 | 1992-04-09 | Abbott Laboratories | Assay using template-dependent nucleic acid probe reorganization |
| DE68908054T2 (de) | 1988-01-21 | 1994-03-10 | Genentech Inc | Verstärkung und nachweis von nukleinsäuresequenzen. |
| CA1340807C (fr) | 1988-02-24 | 1999-11-02 | Lawrence T. Malek | Procede d'amplification d'une sequence d'acide nucleique |
| DE68911648T2 (de) | 1988-03-24 | 1994-06-23 | Univ Iowa Res Found | Katalytische hybridisierungs-systeme zum nachweis von nukleinsäuresequenzen, die auf deren aktivität als kofaktoren in katalytischen reaktionen basieren in denen eine komplementäre, markierte nukleinsäureprobe gespalten wird. |
| WO1993012227A1 (fr) | 1991-12-17 | 1993-06-24 | Genpharm International, Inc. | Animaux transgeniques non humains capables de produire des anticorps heterologues |
| JPH08503489A (ja) | 1992-11-24 | 1996-04-16 | ジー．ディー．サール アンド カンパニー | インターロイキン−３（ｉｌ−３）突然変異ポリペプチド |
| US6171820B1 (en) | 1995-12-07 | 2001-01-09 | Diversa Corporation | Saturation mutagenesis in directed evolution |
| US6562594B1 (en) | 1999-09-29 | 2003-05-13 | Diversa Corporation | Saturation mutagenesis in directed evolution |
| US6764835B2 (en) | 1995-12-07 | 2004-07-20 | Diversa Corporation | Saturation mutageneis in directed evolution |
| US5874304A (en) | 1996-01-18 | 1999-02-23 | University Of Florida Research Foundation, Inc. | Humanized green fluorescent protein genes and methods |
| US7033781B1 (en) | 1999-09-29 | 2006-04-25 | Diversa Corporation | Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| CA2438628A1 (fr) | 2001-02-19 | 2002-08-29 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Proteines artificielles presentant une immunogenicite reduite |
| AU2003303502A1 (en) * | 2002-12-27 | 2004-07-29 | Rosetta Inpharmatics Llc | Computer systems and methods for associating genes with traits using cross species data |
| US7790655B2 (en) | 2005-10-14 | 2010-09-07 | Medimmune, Llc | Cell display of antibody libraries |
| KR101626988B1 (ko) * | 2007-04-03 | 2016-06-02 | 암젠 리서치 (뮌헨) 게엠베하 | 종간 특이적 이중특이적인 결합제들 |
| WO2008119567A2 (fr) * | 2007-04-03 | 2008-10-09 | Micromet Ag | Domaine de liaison spécifique d'espèces croisées |
| US7947495B2 (en) | 2007-11-01 | 2011-05-24 | Abbott Biotherapeutics Corp. | Immunoglobulin display vectors |
| EP2153844A1 (fr) | 2008-08-14 | 2010-02-17 | HAUBECK, Hans-Dieter | Hyaluronidases humaines pour la régénération axonale |
| EP2352763B2 (fr) * | 2008-10-01 | 2022-09-21 | Amgen Research (Munich) GmbH | Anticorps monocaténaires bispécifiques spécifiques d'antigènes cibles de masse moléculaire élevée |
| US10981998B2 (en) * | 2008-10-01 | 2021-04-20 | Amgen Research (Munich) Gmbh | Cross-species-specific single domain bispecific single chain antibody |
| US8312249B1 (en) | 2008-10-10 | 2012-11-13 | Apple Inc. | Dynamic trampoline and structured code generation in a signed code environment |
| JP6193570B2 (ja) | 2009-07-17 | 2017-09-13 | バイオアトラ、エルエルシー | 産生宿主における抗体／タンパク質パフォーマンス及び発現の同時で統合された選択及び進化 |
| FR2957821B1 (fr) | 2010-03-24 | 2014-08-29 | Inst Francais Du Petrole | Nouvelle zone de regeneration du catalyseur divisee en secteurs pour unites catalytiques regeneratives |
| DK3435087T3 (da) | 2010-07-16 | 2023-11-27 | Bioatla Inc | Hidtil ukendte fremgangsmåder til proteinevolution |
| CA2997473C (fr) | 2010-12-31 | 2023-10-03 | Bioatla, Llc | Generation d'anticorps monoclonaux entiers |
-
2015
- 2015-01-07 CN CN201580003187.3A patent/CN105849564B/zh active Active
- 2015-01-07 CA CA2935577A patent/CA2935577C/fr active Active
- 2015-01-07 SG SG10201806532RA patent/SG10201806532RA/en unknown
- 2015-01-07 WO PCT/US2015/010498 patent/WO2015105888A1/fr active Application Filing
- 2015-01-07 EP EP15734951.5A patent/EP3092491B1/fr active Active
- 2015-01-07 DK DK15734951.5T patent/DK3092491T3/en active
- 2015-01-07 ES ES18196116T patent/ES2819865T3/es active Active
- 2015-01-07 ES ES15734951T patent/ES2709388T3/es active Active
- 2015-01-07 US US15/759,739 patent/US11293929B2/en active Active
- 2015-01-07 CN CN202110762919.4A patent/CN113504375B/zh active Active
- 2015-01-07 DK DK18196116.0T patent/DK3447493T3/da active
- 2015-01-07 AU AU2015204840A patent/AU2015204840B2/en active Active
- 2015-01-07 EP EP18196116.0A patent/EP3447493B1/fr active Active
-
2020
- 2020-04-27 AU AU2020202783A patent/AU2020202783B2/en active Active
-
2022
- 2022-02-24 US US17/680,101 patent/US20220341941A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN105849564B (zh) | 2021-06-25 |
| ES2709388T3 (es) | 2019-04-16 |
| EP3092491A1 (fr) | 2016-11-16 |
| EP3092491A4 (fr) | 2017-03-29 |
| AU2020202783B2 (en) | 2022-08-25 |
| DK3092491T3 (en) | 2019-02-11 |
| CN113504375A (zh) | 2021-10-15 |
| DK3447493T3 (da) | 2020-08-17 |
| CA2935577C (fr) | 2023-04-04 |
| EP3447493B1 (fr) | 2020-05-13 |
| EP3092491B1 (fr) | 2018-10-31 |
| US20220341941A1 (en) | 2022-10-27 |
| ES2819865T3 (es) | 2021-04-19 |
| CA2935577A1 (fr) | 2015-07-16 |
| US20180259536A1 (en) | 2018-09-13 |
| AU2015204840B2 (en) | 2020-01-30 |
| WO2015105888A1 (fr) | 2015-07-16 |
| EP3447493A1 (fr) | 2019-02-27 |
| AU2015204840A1 (en) | 2016-05-19 |
| CN113504375B (zh) | 2024-01-09 |
| US11293929B2 (en) | 2022-04-05 |
| CN105849564A (zh) | 2016-08-10 |
| AU2020202783A1 (en) | 2020-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019284081A1 (en) | Food compositions comprising recombinant milk proteins and methods of producing the same | |
| ZA201705114B (en) | Cysteine protease | |
| MX2023008559A (es) | Proteínas de fusión fc heterodiméricas il15/il15ra. | |
| ZA201705113B (en) | Cysteine protease | |
| PH12017500861A1 (en) | Anti-interleukin-33 antibodies and uses thereof | |
| MY198059A (en) | Anti-ox40 antibodies and their uses | |
| EP3708660A3 (fr) | Polypeptides | |
| EP4335874A3 (fr) | Anticorps anti-hla-g et leur utilisation | |
| MX2016016301A (es) | Procesos de siembra en serie y usos de los mismos. | |
| MX2017006127A (es) | Metodos y composiciones para produccion de proteina de clara de huevo. | |
| CY1123622T1 (el) | Τροποποιημενα μηνιγγιτιδοκοκκικα fhbp πολυπεπτιδια | |
| MX2016016886A (es) | Anticuerpos anti-axl. | |
| PH12017502207A1 (en) | Tau-binding antibodies | |
| MX2017016169A (es) | Anticuerpos anti-her2 y metodos de uso. | |
| TR201909037T4 (tr) | Yeni protein deamidaz. | |
| MX2020010951A (es) | Anticuerpos anti-hla-g y utilizacion de los mismos. | |
| MX2017000776A (es) | Polipeptidos fhbp meningococicos modificados. | |
| SG10201902596TA (en) | Novel methods of protein evolution | |
| MX2016000095A (es) | Transtornos neurodegenerativos. | |
| AU2015348922A8 (en) | Codon optimized polynucleotide for high level expression of CRM197 | |
| EA201892624A1 (ru) | Растения, дающие бессемянные плоды | |
| PH12016501689B1 (en) | Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof | |
| MX2017008908A (es) | Proceso para la hidrólisis de queratina empleando proteasas. | |
| PH12020550871A1 (en) | Process for the preparation of opicapone and intermediates thereof | |
| MX2019013124A (es) | Proteinas de fusion de inhibidor de tripsina urinaria (uti). |